MedTrace Logo

Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus

NCT06251895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2024-02-09

No results posted yet for this study

Summary

Diabetic ketoacidosis (DKA) is the most serious metabolic complication of type 1 diabetes mellitus (T1DM). Insulin deficiency and inflammation play a role in the pathogenesis of DKA. The investigators aim to assess the systemic immune-inflammation index (SII) as a marker of severity among T1DM patients with DKA and without infection.

Conditions

Interventions

OTHER

DKA protocol

IV fluids and IV insulin as per guidelines. reference 1-2

Sponsors & Collaborators

  • Jahra Hospital

    lead OTHER

Principal Investigators

  • MOHAMED AON, PHD · Cairo University

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-12-31
Completion
2023-11-11

Countries

  • Kuwait

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251895 on ClinicalTrials.gov